Christopher Haqq
2014 - Atara Biotherapeutics
In 2014, Christopher Haqq earned a total compensation of $910.6K as Chief Medical Officer at Atara Biotherapeutics, a 81% increase compared to previous year.
Compensation breakdown
| Bonus | $168,750 |
|---|---|
| Option Awards | $292,658 |
| Salary | $333,225 |
| Stock Awards | $113,995 |
| Other | $1,994 |
| Total | $910,622 |
Haqq received $333.2K in salary, accounting for 37% of the total pay in 2014.
Haqq also received $168.8K in bonus, $292.7K in option awards, $114K in stock awards and $2K in other compensation.
Rankings
In 2014, Christopher Haqq's compensation ranked 8,003rd out of 13,032 executives tracked by ExecPay. In other words, Haqq earned more than 38.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,003 out of 13,032 | 39th |
Division Manufacturing | 2,967 out of 4,966 | 40th |
Major group Chemicals And Allied Products | 1,006 out of 1,686 | 40th |
Industry group Drugs | 789 out of 1,365 | 42nd |
Industry Biological Products, Except Diagnostic Substances | 139 out of 236 | 41st |
Source: SEC filing on April 29, 2016.
Haqq's colleagues
We found two more compensation records of executives who worked with Christopher Haqq at Atara Biotherapeutics in 2014.